Error in Figure
In the original publication [], there was a mistake in Figure 10 as published. By mistake, we doubled panels B2–B4 and presented them as panels C2–C4 which of course should not be identical to panel B. This error was not intentional; however, we realized that it may lead to confusion among readers. The corrected Figure 10 appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Figure 10.
Adherence of the E. coli LF82 strain to HCT 116 cells (A) in the presence of pectins during a 2 h incubation period. The means of three experiments ± SD are presented. Statistical significance (* p < 0.05) was assessed between the experimental groups and controls (no pectin), which were assumed to be 100%. Representative images of bacteria adhering to untreated HCT 116 cells (B1,C1) and cells treated with PX (B) or PCX (C) at concentrations of 0.125 mg/mL (B2,C2), 0.25 mg/mL (B3,C3), and 0.5 mg/mL (B4,C4). Wright–Giemsa stain, 100× magnification.
Reference
- Maksymowicz, J.; Palko-Łabuz, A.; Sobieszczańska, B.; Chmielarz, M.; Ferens-Sieczkowska, M.; Skonieczna, M.; Wikiera, A.; Wesołowska, O.; Środa-Pomianek, K. The Use of Endo-Cellulase and Endo-Xylanase for the Extraction of Apple Pectins as Factors Modifying Their Anticancer Properties and Affecting Their Synergy with the Active Form of Irinotecan. Pharmaceuticals 2022, 15, 732. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).